News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

This article was first published 8 years ago  » Business » Diabetes medicines, antibiotics to now get cheaper in India

Diabetes medicines, antibiotics to now get cheaper in India

By Zeba Siddiqui
July 16, 2015 10:06 IST
Get Rediff News in your Inbox:

India has extended price caps to 39 more medicines ranging from commonly used diabetes drugs to antibiotics, in the government's latest effort to improve affordability of medicines.

The move impacts multinational drugmakers, like Abbott Laboratories and GlaxoSmithKline Plc, and a number of local firms, including Lupin Ltd, Cadila Healthcare Ltd and Ipca Ltd, all of whom sell drugs added to the list.

A notice posted on the National Pharmaceutical Pricing Authority (NPPA) website late on Wednesday detailed the 39 new drugs, which extend a price control list that already includes more than 652 medicines.

New drugs added to the list include commonly used antibiotics such as azithromycin, combinations of metformin for diabetes, as well as the anti-emetic domperidone.


Get Rediff News in your Inbox:
Zeba Siddiqui
© Copyright 2024 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Moneywiz Live!